Literature DB >> 33674920

U.S. Prescribing of On-and-Off-Label Medications for Alcohol Use Disorder in Outpatient Visits: NAMCS 2014 to 2016.

Joshua D Wallach1, Taeho Greg Rhee2,3, E Jennifer Edelman4, Nilay D Shah5, Stephanie S O'Malley3, Joseph S Ross4,6,7.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33674920      PMCID： PMC8811103          DOI： 10.1007/s11606-021-06668-x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

Review 1.  Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.

Authors:  Raye Z Litten; Bonnie B Wilford; Daniel E Falk; Megan L Ryan; Joanne B Fertig
Journal:  Subst Abus       Date:  2016 Apr-Jun       Impact factor: 3.716

2.  Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.

Authors:  Alex H S Harris; Elizabeth Oliva; Thomas Bowe; Keith N Humphreys; Daniel R Kivlahan; Jodie A Trafton
Journal:  Psychiatr Serv       Date:  2012-07       Impact factor: 3.084

3.  Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population.

Authors:  Haiden A Huskamp; Sharon Reif; Shelly F Greenfield; Sharon-Lise T Normand; Alisa B Busch
Journal:  J Gen Intern Med       Date:  2020-08-04       Impact factor: 5.128

4.  Multiple Psychiatric Morbidity and Continued Use of Naltrexone for Alcohol Use Disorder.

Authors:  Srinivas B Muvvala; Stephanie S O'Malley; Robert Rosenheck
Journal:  Am J Addict       Date:  2020-08-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.